National Institutes of Health Awards $1.47 Million Grant to ASU!
ASU's Dr. Vida Dennis (Photo credit: David Campbell/ASU).
- Grant monies earmarked for biomedical research & diversity to train future scientists -
- News release by Kenneth Mullinax/ASU
Alabama State University has been awarded a $1.47 million grant from the National Institutes of Health (NIH) to train minority students to become future scientists in the field of biomedical sciences. ASU’s Center for NanoBiotechnology (CNBR) will use these funds to continue to diversify its pool of Ph.D. students at Alabama State University in biomedical research through funding from the NIH-National Institute of General Medical Sciences (NIGMS) for its Research Initiative for Scientific Enhancement (RISE) program.
The goals of the NIGMS-RISE program are to continue to provide support to medical science (MS) students in Biology and enrich the research environment at ASU with a primary focus on intense training and mentoring of participating students for completion of their Ph.D. programs in the field of biomedical research or behavioral sciences. Alabama State's CNBR has partnered with several external research institutions in the nation that will work with ASU to help mentor and train its MS students, which will help make them highly competitive for entry to research-focused Ph.D. programs in the biomedical fields.
With the grant funding from the NIH, many MS graduate students and research scientists at ASU will be able to expand their scientific capabilities in biomedical research. A team of ASU faculty researchers will mentor and supervise students’ research projects and will also help in the implementation of research and educational program activities during the 5-year funding cycle of this grant.
ASU's Dr. Vida A. Dennis, professor of Microbiology and co-director of the CNBR at the University will manage the project while Dr. Shree Singh, professor of Microbiology and director of the CNBR will serve as the project's principal investigator.
News media contact: Kenneth Mullinax, 334-229-4104.